Atlas Trials

Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy

Clinical trial NCT07743541 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07743541
Sponsor
Tubulis GmbH
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Uterine Endometrial Cancer
Start date
2026-10-01
Primary completion
2029-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.